BioSciences Managers – BioScience Managers

Zimmer Biomet and Canary Medical Announce FDA De Novo Classification Grant and Authorization to Market the World’s First and Only Smart Knee Implant

17th September 2021/in BioSciences Managers, Canary Medical, Uncategorised

Link to full article August 30, 2021— Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Canary Medical, a medical data company, today announced U.S. Food and Drug Administration (FDA) DeNovo classification grant and authorization to market the tibial extension for PersonaIQ®, the world’s first and only smart knee cleared […]

CalciMedica Reports Topline Data from the AuxoraTM CARDEA Phase 2 COVID-19 Pneumonia Clinical Trial

15th September 2021/in BioSciences Managers, Calcimedica

Link to full article Reduction in time to recovery through day 60 in patients with moderate and severe respiratory failure (primary endpoint analysis) Statistically significant reduction in time to recovery through day 60 in all patients who received study drug (a pre-specified supplementary analysis of the primary endpoint) Statistically significant 56% relative risk reduction in […]

CalciMedica Announces Publication of Preclinical Data in Journal of Immunology Further Validating Calcium Release-Activated Calcium (CRAC) Channels as Drug Targets for Diseases of the Airways

15th September 2021/in BioSciences Managers, Calcimedica

Link to full article Data provides further evidence of the broad potential for CRAC channel inhibitors to benefit patients across multiple disease areas involving the lungs LA JOLLA, Calif., September 9, 2021 – CalciMedica Inc. (“CalciMedica” or the “Company”), the CRAC channel company, today announced the publication of preclinical data validating calcium release-activated calcium (CRAC) channels, P2Y2 […]

Spray-on skin technology saving lives of many in Australia and around the world

10th September 2021/in Avita Medical, BioSciences Managers

The Bali bombing in 2002 caused the shocking deaths of 202 people, including 88 Australians. A further 209 were injured, many with disfiguring burns. But thanks to plastic surgeon Professor Fiona Wood, from the Royal Perth Hospital, a spray-on skin she invented saved many lives. RECELL continues to do so today around the world, thanks […]

BIOSCIENCE MANAGERS: This biotech focused fund explains why it invested $15m in these 2 ASX stocks

11th February 2021/in Acrux, BioSciences Managers, Cynata

Link to Full Article MoneyTalks is Stockhead’s regular recap of the ASX stocks and sectors that fund managers and analysts are looking at right now. Today we hear from BioScience Managers’ managing partner Dr Graham Crooke. BioScience Managers is an Australian life sciences investor established in 2003 and has a solid investment record making over 200 investments across […]

BioScience Managers Proud to Receive Prestigious Michael Hirshorn Award

9th December 2020/in BioSciences Managers

Melbourne, Australia 9 December 2020: Leading Australian-based healthcare investment firm BioScience Managers Pty Ltd is thrilled and honoured to receive the Michael Hirshorn Award for 2020, as part of the Australian Investment Council Investing for Growth Awards 2020. Instituted in 2012, and named in honour of the late Michael Hirshorn, co-founder and CEO of Cochlear, the […]

New industry Advisory Group Chairs appointed by AusBiotech

3rd September 2020/in BioSciences Managers

Link to Full Article AusBiotech welcomes its new industry Advisory Group Chairs: Dr Megan Robertson, St Vincent’s Hospital Melbourne, Chair of the AusBiotech Clinical Trials Adivsory Group; and Dr Amanda Gillon, Bioscience Managers, Chair of the AusBiotech Investor Advisory Group. AusBiotech’s national advisory groups and state branch committees are important mechanisms to highlight and address […]

BioScience Managers invests in CSIRO-derived microencapsulation technology

8th August 2019/in BioSciences Managers, Pharmamark

Melbourne, Australia and London, UK 8 August 2019 – BioScience Managers (BSM), one of Australia’s leading international healthcare investment firms, today announces an investment in Sydney-based nutrition technology company, Pharmamark Nutrition Pty. Ltd. BSM has invested A$5.5 million in Pharmamark Nutrition. The funds will go toward the development of CSIRO’s microencapsulation technology for Pharmamark’s IntEncap™ product […]

Healthcare Investing: Wealth Managers Chart Way Forward

17th April 2019/in BioSciences Managers

Link to full Article Will Brooks and Jeremy Curnock Cook, 17 April 2019 The healthcare sector has seen huge investment growth and more specialised products starting to emerge. Two specialists navigate what is on offer. Global spending on healthcare is projected to reach $10 trillion by 2022. Venture capital flowing into UK medtech companies has […]

UK biotech industry surges by 65%, giving hope· as Brexit looms

4th April 2019/in BioSciences Managers

London and Oxbridge ‘Golden Triangle’ retains top position, hosting 1 in 3 biotechs The number of UK biotechs has increased by 65% in the last three years, according to analysis by London -based investment management firm Downing LLP. The growth has been fueled by record levels of investment as the UK biotech industry attracted £2.2 […]